3 clinical trials found.
-
S1418/BR006 A Randomized Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy.
If you have been diagnosed with triple negative breast cancer (TNBC) you may qualify to participate in a clinical trial investigating the investigational drug ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
Pre-surgical Evaluation of Denosumab in Patients With Operable Invasive Breast Cancer
The goal of this Phase 0 (biomarker) study is to evaluate tumor-specific biomarkers of RANK/RANKL expression in early breast cancer. It will also provide ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
The goal of this Phase II study is to evaluate the safety/tolerability and clinical activity of the combination of nab-paclitaxel and the antibody against ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
